Danielle Porter

8.8k citations
77 papers · 6.4k · 5 hit papers · h-index 32

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • Viral gastroenteritis research and epidemiology
    • HIV/AIDS drug development and treatment
    • Viral Infections and Outbreaks Research
  • Virology top 2%

Papers in

    • SARS-CoV-2 and COVID-19 Research 28
    • COVID-19 Clinical Research Studies 19
    • HIV/AIDS drug development and treatment 19
    • Viral Infections and Outbreaks Research 16
    • Viral Infections and Vectors 10
    • Viral gastroenteritis research and epidemiology 7
    • Respiratory viral infections research 15

Danielle Porter

72 papers receiving 6.2k citations

Danielle Porter's Hit Papers

Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms 2022 · 178 citations
1780+2+4Years since publication4008001.2k

Peers

Danielle Porter
Comparison fields: 5 of 130
  • Infectious Diseases 4.9k
  • Virology 314
  • Neurology 720
  • Computational Theory and Mathematics 559
  • Modeling and Simulation 139
Replace Darius M. Babusis with:
Darius M. Babusis United States
Joy Y. Feng United States
Timothy H. Burgess United States
Michèle van Vugt Netherlands
Leon Caly Australia
Michael O. Clarke United States
Scott Sellers United States
Anuj Gaggar United States
Alexander Zoufaly Austria
Leen Delang Belgium
Danielle Porter relative to Darius M. Babusis United States Darius M. Babusis's profile →
Citations per field
00.5×1.5×
Darius M. Babusis · 1×
Citations per year

Countries citing papers authored by Danielle Porter

Since Specialization
Citations

This map shows the geographic impact of Danielle Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Porter more than expected).

Fields of papers citing papers by Danielle Porter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Porter. The network helps show where Danielle Porter may publish in the future.

Co-authors

The 25 scholars most cited alongside Danielle Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Danielle Porter Line = papers co-authored together Danielle Porter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Hit paper breakdown →
20201343
2
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Hit paper breakdown →
2020780
3 2020659
4
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Hit paper breakdown →
2020562
5
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Hit paper breakdown →
2019493
6 2020391
7
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms
Hit paper breakdown →
2022178
8 2020129
9 2013110
10 2021109
11 2013102
12 201499
13 202168
14 201768
15 202064
16 201962
17 201962
18 202260
19 202052
20 202047

About Danielle Porter

Danielle Porter is a scholar working on Infectious Diseases, Epidemiology, Virology, Cardiology and Cardiovascular Medicine and Emergency Medical Services, having authored 77 papers that have together received 6.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (28 papers), COVID-19 Clinical Research Studies (19 papers), HIV/AIDS drug development and treatment (19 papers), Viral Infections and Outbreaks Research (16 papers), Respiratory viral infections research (15 papers), Viral Infections and Vectors (10 papers), Viral gastroenteritis research and epidemiology (7 papers) and Viral Infections and Immunology Research (5 papers). The work is most often cited by research in Infectious Diseases (4.9k citations), Virology (314 citations), Neurology (720 citations), Computational Theory and Mathematics (559 citations) and Modeling and Simulation (139 citations). Danielle Porter has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Joy Y. Feng, Matthias Götte, Egor Petrovitch Tchesnokov, Calvin J. Gordon, Jason K. Perry, Emma Woolner, Tomáš Cihlář, Timothy P. Sheahan, Darius M. Babusis and Ralph Steven Baric. Their work appears in journals such as Viruses, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, Antiviral Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact